loadpatents
name:-0.050315141677856
name:-0.03522801399231
name:-0.022423028945923
Zhu; Zhongyu Patent Filings

Zhu; Zhongyu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhu; Zhongyu.The latest application filed is for "chimeric antigen receptors containing glypican 2 binding domains".

Company Profile
24.37.53
  • Zhu; Zhongyu - Frederick MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
Grant 11,453,719 - Orentas , et al. September 27, 2
2022-09-27
Chimeric Antigen Receptors Containing Glypican 2 Binding Domains
App 20220257653 - BOSSE; Kristopher ;   et al.
2022-08-18
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy
Grant 11,389,480 - Oppenheim , et al. July 19, 2
2022-07-19
Compositions And Methods For Treating Cancer With Anti-bcma Immunotherapy
App 20210361709 - Schneider; Dina ;   et al.
2021-11-25
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
App 20210353675 - Schneider; Dina ;   et al.
2021-11-18
Monoclonal Antibodies Specific For Fibroblast Growth Factor Receptor 4 (fgfr4) And Methods Of Their Use
App 20210324090 - Khan; Javed ;   et al.
2021-10-21
Affinity Matured Cd22-specific Monoclonal Antibody And Uses Thereof
App 20210324074 - Dimitrov; Dimiter S. ;   et al.
2021-10-21
Compositions and methods for treating cancer with anti-CD38 immunotherapy
Grant 11,103,533 - Schneider , et al. August 31, 2
2021-08-31
Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use
Grant 11,078,286 - Khan , et al. August 3, 2
2021-08-03
Compositions and methods for treating cancer with anti-BCMA immunotherapy
Grant 11,052,112 - Schneider , et al. July 6, 2
2021-07-06
Compositions and methods for treating cancer with anti-CD38 immunotherapy
Grant 11,045,497 - Schneider , et al. June 29, 2
2021-06-29
Monoclonal Antibodies That Specifically Bind To Matrilin 3 And Their Use
App 20210179700 - Baron; Jeffrey ;   et al.
2021-06-17
Combination therapies targeting tumor-associated stroma or tumor cells and microtubules
Grant 11,033,620 - Saha , et al. June 15, 2
2021-06-15
Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature
Grant 11,034,757 - Saha , et al. June 15, 2
2021-06-15
Combination therapies targeting tumor-associated stroma or tumor cells
Grant 11,033,621 - Saha , et al. June 15, 2
2021-06-15
Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy
App 20210130479 - Orentas; Rimas J. ;   et al.
2021-05-06
Monoclonal antibodies that specifically bind to matrilin-3 and their use
Grant 10,954,291 - Baron , et al. March 23, 2
2021-03-23
Compositions and methods for treating cancer with anti-CD123 immunotherapy
Grant 10,844,128 - Orentas , et al. November 24, 2
2020-11-24
Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents
Grant 10,799,584 - Saha , et al. October 13, 2
2020-10-13
Compositions And Methods For Treating Cancer With Anti-bcma Immunotherapy
App 20200289572 - Schneider; Dina ;   et al.
2020-09-17
Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase
Grant 10,758,614 - Saha , et al. Sep
2020-09-01
Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways
Grant 10,758,526 - Saha , et al. Sep
2020-09-01
Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells
Grant 10,758,613 - Saha , et al. Sep
2020-09-01
Anti-cd276 Polypeptides, Proteins, And Chimeric Antigen Receptors
App 20200255534 - Kind Code
2020-08-13
Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy
App 20200231663 - Orentas; Rimas ;   et al.
2020-07-23
Human Monoclonal Antibody Targeting Tnfr2 For Cancer Immunotherapy
App 20200230173 - Oppenheim; Joost J. ;   et al.
2020-07-23
Anti-cd276 Antibodies (b7h3)
App 20200199246 - Dimitrov; Dimiter S. ;   et al.
2020-06-25
Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy
App 20200197440 - Schneider; Dina ;   et al.
2020-06-25
Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy
App 20200155661 - Orentas; Rimas J. ;   et al.
2020-05-21
Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy
App 20200123254 - Schneider; Dina ;   et al.
2020-04-23
Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy
App 20200102385 - Orentas; Rimas J. ;   et al.
2020-04-02
Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy
App 20200101109 - Orentas; Rimas ;   et al.
2020-04-02
Anti-CD276 antibodies (B7H3)
Grant 10,604,582 - Dimitrov , et al.
2020-03-31
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
Grant 10,604,583 - Orentas , et al.
2020-03-31
Compositions and methods for treating cancer with anti-mesothelin immunotherapy
Grant 10,550,179 - Orentas , et al. Fe
2020-02-04
Antibody-drug conjugates for targeting CD56-positive tumors
Grant 10,548,987 - Dimitrov , et al. Fe
2020-02-04
Compositions and methods for treating cancer with anti-CD22 immunotherapy
Grant 10,543,263 - Orentas , et al. Ja
2020-01-28
Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy
App 20200010555 - Orentas; Rimas J. ;   et al.
2020-01-09
Compositions and methods for treating cancer with anti-CD19 immunotherapy
Grant 10,501,539 - Schneider , et al. Dec
2019-12-10
Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells
Grant 10,434,174 - Saha , et al. O
2019-10-08
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
Grant 10,428,141 - Orentas , et al. October 1, 2
2019-10-01
Compositions and methods for treating cancer with anti-CD33 immunotherapy
Grant 10,426,797 - Orentas , et al. October 1, 2
2019-10-01
Cartilage Targeting Agents And Their Use
App 20190248880 - Baron; Jeffrey ;   et al.
2019-08-15
Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy
App 20190218280 - Orentas; Rimas J. ;   et al.
2019-07-18
Agents that specifically bind matrilin-3 and their use
Grant 10,323,083 - Baron , et al.
2019-06-18
Compositions and Methods For Treating Cancer With Anti-CD19 Immunotherapy
App 20190106492 - Schneider; Dina ;   et al.
2019-04-11
Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy
App 20190099476 - Orentas; Rimas J. ;   et al.
2019-04-04
Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy
App 20190055309 - Orentas; Rimas J. ;   et al.
2019-02-21
TEM8 antibodies and their use in treatment and detection of tumors
Grant 10,196,443 - Dimitrov , et al. Fe
2019-02-05
Compositions and methods for treating cancer with anti-mesothelin immunotherapy
Grant 10,183,993 - Orentas , et al. Ja
2019-01-22
Monoclonal Antibodies Specific For Fibroblast Growth Factor Receptor 4 (fgfr4) And Methods Of Their Use
App 20180318440 - Khan; Javed ;   et al.
2018-11-08
Glypican 2 As A Cancer Marker And Therapeutic Target
App 20180318444 - MARIS; John M. ;   et al.
2018-11-08
Compositions and Methods for Treating Cancer with Anti-CD33 Immunotherapy
App 20180280438 - Orentas; Rimas ;   et al.
2018-10-04
Antibody-drug Conjugates For Targeting Cd56-positive Tumors
App 20180214568 - Dimitrov; Dimiter S. ;   et al.
2018-08-02
Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy
App 20180208645 - Orentas; Rimas ;   et al.
2018-07-26
Anti-cd276 Antibodies (b7h3)
App 20180186890 - Dimitrov; Dimiter S. ;   et al.
2018-07-05
Anti-cd276 Polypeptides, Proteins, And Chimeric Antigen Receptors
App 20170369585 - Orentas; Rimas J. ;   et al.
2017-12-28
Tem8 Antibodies And Their Use In Treatment And Detection Of Tumors
App 20170355765 - Dimitrov; Dimiter ;   et al.
2017-12-14
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
Grant 9,790,282 - Orentas , et al. October 17, 2
2017-10-17
TEM8 antibodies and their use in treatment and detection of tumors
Grant 9,765,142 - Dimitrov , et al. September 19, 2
2017-09-19
HER2-specific monoclonal antibodies and conjugates thereof
Grant 9,738,726 - Dimitrov , et al. August 22, 2
2017-08-22
Cross-reactive Antibodies Against Dengue Virus And Uses Thereof
App 20170218052 - DIMITROV; Dimiter S. ;   et al.
2017-08-03
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
Grant 9,676,846 - Dimitrov , et al. June 13, 2
2017-06-13
Combination Therapies Targeting Tumor-associated Stroma Or Tumor Cells And Microtubules
App 20170119881 - Saha; Saurabh ;   et al.
2017-05-04
Combination Therapies Using Platinum Agents And Agents That Target Tumor-associated Stroma Or Tumor Cells
App 20170119883 - Saha; Saurabh ;   et al.
2017-05-04
Combination Therapies Targeting Tumor-associated Stroma Or Tumor Cells
App 20170119882 - Saha; Saurabh ;   et al.
2017-05-04
Combination Therapies Using Agents That Target Tumor-associated Stroma Or Tumor Cells And Alkylating Agents
App 20170112927 - Saha; Saurabh ;   et al.
2017-04-27
Combination Therapies Targeting Tumor-associated Stroma Or Tumor Cells And Topoisomerase
App 20170112928 - Saha; Saurabh ;   et al.
2017-04-27
Combination Therapies Using Anti-metabolites And Agents That Target Tumor-associated Stroma Or Tumor Cells
App 20170112926 - Saha; Saurabh ;   et al.
2017-04-27
Combination Therapies Using Agents That Target Tumor-associated Stroma Or Tumor Cells And Tumor Vasculature
App 20170101464 - Saha; Saurabh ;   et al.
2017-04-13
Combination Therapies Using Agents That Target Tumor-associated Stroma Or Tumor Cells And Other Pathways
App 20170095575 - Saha; Saurabh ;   et al.
2017-04-06
Cross-reactive antibodies against dengue virus and uses thereof
Grant 9,556,254 - Dimitrov , et al. January 31, 2
2017-01-31
Cartilage Targeting Agents And Their Use
App 20160340418 - Baron; Jeffrey ;   et al.
2016-11-24
Tem8 Antibodies And Their Use
App 20160264662 - Dimitrov; Dimiter ;   et al.
2016-09-15
Her2-specific Monoclonal Antibodies And Conjugates Thereof
App 20160130359 - Dimitrov; Dimiter S. ;   et al.
2016-05-12
Anti-cd276 Polypeptides, Proteins, And Chimeric Antigen Receptors
App 20160053017 - Orentas; Rimas J ;   et al.
2016-02-25
Human Monoclonal Antibodies That Bind Insulin-like Growth Factor (igf) I And Ii
App 20160024199 - Dimitrov; Dimiter S. ;   et al.
2016-01-28
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
Grant 9,150,644 - Dimitrov , et al. October 6, 2
2015-10-06
Cross-reactive Antibodies Against Dengue Virus And Uses Thereof
App 20150218255 - Dimitrov; Dimiter S. ;   et al.
2015-08-06
Human Monoclonal Antibodies Against Hendra and Nipah Viruses
App 20150071854 - Dimitrov; Dimiter S. ;   et al.
2015-03-12
Human monoclonal antibodies against Hendra and Nipah viruses
Grant 8,858,938 - Dimitrov , et al. October 14, 2
2014-10-14
Human Monoclonal Antibodies Against Hendra and Nipah Viruses
App 20140079715 - Dimitrov; Dimiter S. ;   et al.
2014-03-20
Human Monoclonal Antibodies That Bind Insulin-like Growth Factor (igf) I And Ii
App 20140044720 - Dimitrov; Dimiter S. ;   et al.
2014-02-13
Human Monoclonal Antibodies Against Hendra and Nipah Viruses
App 20130149246 - Dimitrov; Dimiter S. ;   et al.
2013-06-13
Human monoclonal antibodies against hendra and nipah viruses
Grant 8,313,746 - Dimitrov , et al. November 20, 2
2012-11-20
Human Monoclonal Antibodies Against Hendra And Nipah Viruses
App 20120064000 - Dimitrov; Dimiter S. ;   et al.
2012-03-15
Human monoclonal antibodies that bind human insulin like growth factors and their use
Grant 8,071,323 - Dimitrov , et al. December 6, 2
2011-12-06
Antibody Compositions And Methods For Treatment Of Neoplastic Disease
App 20100055033 - Dimitrov; Dimiter S. ;   et al.
2010-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed